Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS)

Diabetes Care - United States
doi 10.2337/dc16-1135
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Pancreatic Safety of Sitagliptin in the TECOS Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2016English

Cardiovascular Safety of Sitagliptin in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients With Type 2 Diabetes: The EDIT Randomized Trial

PLoS ONE
Multidisciplinary
2015English

The Risk of Pancreatitis With Sitagliptin Therapy in Older Adults: A Population-Based Cohort Study

CMAJ Open
2015English

Cardiovascular Effects of Sitagliptin --An Anti-Diabetes Medicine

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

The Durability of Sitagliptin in Elderly Patients With type 2 Diabetes

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2014English

Sitagliptin-Associated Angioedema

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2012English

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

Endocrine Journal
EndocrinologyMetabolismDiabetes
2016English

A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy